A clean, intact seal ensures consistent dose delivery
As FDA states in their guidance document on the Q-Submission program, Early interaction with FDA on planned non-clinical and clinical studies and careful consideration of FDAs feedback may improve the quality of subsequent submissions, shorten total review times, and facilitate the development process for new devices. While this is not meant to be a general pre-review of your submission, it is there to help you get answers to questions directly from FDAwhich will contribute to a smooth submission and, hopefully, approval
Periventricular leukomalacia Periventricular leukomalacia (PVL) is a diffuse damage of the cerebral white matter that extends beyond the periventricular regions found predominantly in preterm infants
The FDA also highlights safety concerns regarding certain bulk substances used in compounding, as well as broader compounding risks
10.1021/bi00064a021 19 GutscherM.PauleauA.-L.MartyL.BrachT.WabnitzG
The book is highly recommended for researchers in the field of sleep neurobiology, although some minor weaknesses such as content overlap and the absence of certain topics are noted
